Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
AL amyloidosis is a rare protein disorder that can be often fatal if it is not diagnosed and managed early. This disorder is caused by misfolding of proteins that clump together and form amyloid fibril deposits in major body organs. Diagnosis of AL amyloidosis is often not easy as the signs and symptoms can be mistaken for common diseases. The median survival rate after diagnosis is less than six months when the underlying plasma cell dyscrasia is left untreated in AL amyloidosis patients. Hence, it is paramount to develop novel diagnostic methodologies that are not based on the signs and symptoms of AL amyloidosis, but are based on the underlying molecular mechanisms of amyloidogenic clone, which can provide evidences for predisposition much long before the disease sets its course on the body. We propose to develop a machine learning technique to predict whether a light chain amino acid sequence will form proteins that misfold and produce amyloid fibrils, leading to AL amyloidosis.
Bin Ma;Lila Kari
Anupa Murali
Rapid Novor Inc
Computer science
Professional, scientific and technical services
University of Waterloo
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.